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L
ymphedema is a chronic, incurable condition 
caused by the anomalous development of the 
lymphatic system (primary lymphedema) or 
injury to lymphatic vasculature (secondary lymph-
edema). The disease affects millions of persons 
worldwide and most commonly involves the extremi-
ties. Fluid accumulates in the interstitial space, caus-
ing enlargement of the affected area. Complications 
of lymphedema include psychosocial morbidity, in-
fection, functional disability, skin changes, and ma-
lignant transformation.1
Primary lymphedema is idiopathic, rare, and typi-
cally presents during infancy, childhood, or adoles-
cence. Secondary lymphedema is the most common 
cause of the disease and usually results from either a 
parasitic infection or following nodal radiation and 
lymphadenectomy. Recently, we have shown that ex-
treme obesity may be a novel cause of lymphedema.2 
Patients with a body mass index (BMI) greater than 
59 were found to have lower extremity lymphedema, 
whereas obese individuals with a BMI between 30 
and 53 had normal lower extremity lymphatic func-
tion.2 Patients in this study were referred for lower 
extremity lymphedema, and thus, only the lymphatic 
function of their legs was studied. We now report the 
first patient with obesity-induced lymphedema in-
volving the upper limbs.
CASE REPORT
A 62-year-old man was referred to our Lymphede-
ma Program with bilateral upper and lower extrem-
ity lymphedema (Fig. 1). He was 5 feet 10 inches tall 
(179  cm) and weighed 420 pounds (191  kg); his BMI 
was 60.3. He had lost weight by dieting over the previ-
ous 10 years since he was at his maximum weight of 
736 pounds (BMI, 105.6). He complained of difficul-
ty using his extremities and periodic infections of his 
lower limbs. His medical history was significant for a 
herniated disk, asthma, chronic obstructive pulmonary 
disease, transurethral resection of the prostate, and 
herniorrhaphy. His medications included lisinopril, 
percocet, and diazepam. Other than his BMI, he did 
not have any risk factors for lymphedema (eg, primary 
lymphedema, penetrating trauma, lymphadenecto-
my, and radiation). On physical examination, he had 
pitting edema of all 4 extremities. To determine his 
extremity lymphatic function, he underwent lympho-
scintigraphy, which is 100% specific and 92% sensitive 
for lymphedema.3–6 His lymphoscintigram showed lym-
phatic dysfunction of all 4 extremities, with delayed 
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Summary: Obesity increases the risk of upper extremity lymphedema fol-
lowing treatment for breast cancer and can cause lower extremity lym-
phatic dysfunction in extremely obese individuals. We report the first 
patient with obesity-induced upper extremity lymphedema. A 62-year-old 
man with a previous body mass index (BMI) of 105.6, presented with a 
BMI 60.3 following weight loss. He complained of lymphedema of all 4 
extremities, which was confirmed by lymphoscintigraphy. Because the up-
per limbs are more resistant to lymphedema than the lower extremities, 
a higher BMI threshold may be necessary to cause upper extremity lym-
phatic dysfunction. (Plast Reconstr Surg Glob Open 2013;1:e59; doi: 10.1097/
GOX.0b013e3182a96359; Published   online 23 October 2013.)
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transit to the inguinal and axillary lymph nodes. The 
patient was managed with static and pneumatic com-
pression and was referred to a bariatric center.
DISCUSSION
Obesity, which affects one third of the population 
in the United States,7 negatively affects lymphatic 
function. Not only does obesity increase the risk of 
lymphedema following lymphadenectomy and radi-
ation to the axilla,8–11 but it may cause the disease in 
extremely obese individuals (BMI, >59).2 Previously, 
obese patients referred to our center complained 
of lower extremity enlargement, and thus, only the 
lymphatic function of their legs was assessed using 
lymphoscintigraphy. The patient in this report was 
the first to present with upper extremity edema as 
well, and he was found to have lymphatic dysfunc-
tion of all of his limbs. His maximum BMI of 105 
was the highest of the cohort of patients managed 
in our Lymphedema Program. The patient we have 
treated with the next highest BMI (88) had bilat-
eral lower extremity lymphedema but did not com-
plain of upper extremity edema. A BMI threshold 
may exist above 88 at which point upper extremity 
lymphatic dysfunction might develop, similar to the 
threshold between 54 and 59 at which point lower 
extremity lymphedema seems to occur. The up-
per limbs should be more resistant to developing 
obesity-induced lymphedema, compared with the 
lower extremities, because: (1) adipose deposition 
in obese patients preferentially affects the legs, (2) 
lymph drainage from the upper limbs is closer to the 
central venous circulation, and (3) the arms are less 
affected by having to transport lymph against gravity.
Obesity may reduce lymphatic function by either 
(1) impairing the function of lymphatic vessels and/
or (2) overwhelming normally functioning lymphat-
ics with increased lymph production. An obese limb 
may compress lymphatics or the adipose tissue might 
cause inflammation which damages the lymphatic 
vasculature. Alternatively, as the size of the obese ex-
tremity increases, the elevated production of lymph 
may overwhelm the capacity of the lymphatics to 
transport the fluid proximally.
Obesity-induced lymphedema may prove to be the 
only example of lymphedema that is reversible. Follow-
ing weight loss through diet or a bariatric procedure, 
lymphatic clearance may improve because of reduced 
lymph production and/or by restored function of lym-
phatic vessels. If lymphatic function does not reverse 
following massive weight loss, then the mechanism for 
the disease would be less likely elevated lymph produc-
tion and more likely injury to lymphatic vasculature 
Fig. 1. a 62-year-old man with a maximum BMI history of 105.6, presented with a BMI of 60.3 after dieting. He complained 
of swelling of all 4 limbs (a and D). extremity lymphoscintigraphy showed absence of tracer in the axillary (B) and inguinal 
nodes (e) 45 min following radiolabelled colloid injection into the hands and feet (normal transit time to the axillary and 
inguinal nodes is <45 min).3–6 Minimal, delayed tracer accumulation into the axillary (C) and inguinal nodes (F) occurred 2 h 
after injection. these findings indicated lymphatic dysfunction of all 4 extremities consistent with lymphedema.3–6   arrows 
indicate nodal uptake of radiolabelled tracer. 
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which cannot be reversed following weight loss. If 
lymphedema proves to be irreversible following mas-
sive weight loss, then patients should undergo a bariat-
ric procedure before reaching a BMI threshold when 
lymphatic dysfunction occurs. Unlike other comorbid-
ities that improve following weight loss (eg, diabetes, 
hypertension, and hypercholesterolemia), patients 
would continue to suffer from lymphedema.
CONCLUSIONS
Extreme obesity previously has been associated 
with lower extremity lymphedema. We present a pa-
tient with a maximum BMI history of 105 who was 
referred with bilateral arm and leg lymphedema. 
Lymphoscintigraphy confirmed lymphatic dysfunc-
tion of all 4 limbs. Severe obesity may be a novel 
cause of upper extremity lymphedema. 
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